| Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer (NCT04044430) | University of California, San Francisco | 2020-08-31 |
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190) | Stanford University | 2017-08-08 |
| CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery (NCT02232152) | Wake Forest University Health Sciences | 2015-01-06 |
| Programs to Support You During Chemotherapy (Pro-You) (NCT02148406) | Vanderbilt-Ingram Cancer Center | 2014-08-01 |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520) | City of Hope Medical Center | 2013-10-01 |
| Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy (NCT01934179) | Fox Chase Cancer Center | 2013-10-01 |
| PET-MRI in Diagnosing Patients With Colon or Rectal Cancer (NCT01807117) | Case Comprehensive Cancer Center | 2013-04-01 |
| Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery (NCT01802320) | National Cancer Institute (NCI) | 2013-03-01 |
| Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer (NCT01741636) | City of Hope Medical Center | 2013-01-01 |
| Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors (NCT01131234) | National Cancer Institute (NCI) | 2010-05-01 |
| Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma (NCT00754494) | National Cancer Institute (NCI) | 2008-07-01 |
| SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT00103311) | National Cancer Institute (NCI) | 2005-01-01 |
| A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer (NCT00060411) | National Cancer Institute (NCI) | 2003-06-01 |
| Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer (NCT00005036) | National Cancer Institute (NCI) | 1999-11-01 |
| Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer (NCT02575508) | Roswell Park Cancer Institute | |